St. Jude Medical, Inc (NYSE:STJ) shares moved down -5.03% to settle at $38.91 with the total traded volume of 8.60 million shares more than average volume of 3.26 million shares. Its market capitalization was $12.47 billion.Source Link: http://www.investorschatroom.com/healthcare-sector-stocks-does-not-care-investors-wealth/
Who in the devil is giving advice to the CEO and his munckins? How better to continue an issue and explode in in the market? Can there be no adult giving this poor schmuck adice?
I was reading a piece last night regarding the PR. I think it could be the response to the lead problem. Seems it could garner more a negative impressions for the company.